- Home
- PCVX vs MC Comparison
PCVX vs MC Comparison
Compare PCVX & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- MC
- Stock Information
- Founded
- PCVX 2013
- MC 2007
- Country
- PCVX United States
- MC United States
- Employees
- PCVX N/A
- MC N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- MC Investment Managers
- Sector
- PCVX Health Care
- MC Finance
- Exchange
- PCVX Nasdaq
- MC Nasdaq
- Market Cap
- PCVX 4.4B
- MC 4.2B
- IPO Year
- PCVX 2020
- MC 2014
- Fundamental
- Price
- PCVX $33.27
- MC $65.47
- Analyst Decision
- PCVX Strong Buy
- MC Hold
- Analyst Count
- PCVX 10
- MC 7
- Target Price
- PCVX $136.50
- MC $64.17
- AVG Volume (30 Days)
- PCVX 1.5M
- MC 881.5K
- Earning Date
- PCVX 08-05-2025
- MC 07-23-2025
- Dividend Yield
- PCVX N/A
- MC 3.97%
- EPS Growth
- PCVX N/A
- MC N/A
- EPS
- PCVX N/A
- MC 2.29
- Revenue
- PCVX N/A
- MC $1,283,653,000.00
- Revenue This Year
- PCVX N/A
- MC $10.42
- Revenue Next Year
- PCVX N/A
- MC $19.33
- P/E Ratio
- PCVX N/A
- MC $28.64
- Revenue Growth
- PCVX N/A
- MC 45.14
- 52 Week Low
- PCVX $27.66
- MC $47.00
- 52 Week High
- PCVX $121.06
- MC $82.89
- Technical
- Relative Strength Index (RSI)
- PCVX 46.99
- MC 70.55
- Support Level
- PCVX $32.00
- MC $61.45
- Resistance Level
- PCVX $34.63
- MC $63.90
- Average True Range (ATR)
- PCVX 1.31
- MC 1.61
- MACD
- PCVX -0.08
- MC 0.69
- Stochastic Oscillator
- PCVX 37.46
- MC 98.19
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About MC Moelis & Company
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.